AEON Biopharma, Inc.

Biotechnology • Healthcare • Irvine, CA, United States • AEON (ASE)

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Midday Stock Roundup: Rivian Down on Production Totals - Orange County Business Journal

Orange County Business Journal • Jan 2

AEON Biopharma (NYSE: AEON) agrees Daewoong swap cutting over 90% of debt - Stock Titan

Stock Titan • Dec 15

AEON Biopharma (AEON) Price Target Decreased by 15.28% to 6.22 - Nasdaq

Nasdaq • Dec 5

AEON's ABP-450 Achieves Critical Analytical Milestone, Demonstrating High Biosimilarity to BOTOX - Dermatology Times

Dermatology Times • Nov 17

AEON Biopharma Announces Exchange Agreement with Daewoong - TipRanks

TipRanks • Dec 15

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has AEON Biopharma, Inc. had layoffs?

No layoff events have been recorded for AEON Biopharma, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does AEON Biopharma, Inc. have?

AEON Biopharma, Inc. has approximately 5 employees.

What industry is AEON Biopharma, Inc. in?

AEON Biopharma, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is AEON Biopharma, Inc. a publicly traded company?

Yes, AEON Biopharma, Inc. is publicly traded under the ticker symbol AEON on the ASE. The company has a market capitalization of approximately $0.01 billion.

Where is AEON Biopharma, Inc. headquartered?

AEON Biopharma, Inc. is headquartered in Irvine, CA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.